Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens

Antimicrobial Agents and Chemotherapy
Roland R RegoesBruce R Levin

Abstract

There is a complex quantitative relationship between the concentrations of antibiotics and the growth and death rates of bacteria. Despite this complexity, in most cases only a single pharmacodynamic parameter, the MIC of the drug, is employed for the rational development of antibiotic treatment regimens. In this report, we use a mathematical model based on a Hill function-which we call the pharmacodynamic function and which is related to previously published E(max) models-to describe the relationship between the bacterial net growth rates and the concentrations of antibiotics of five different classes: ampicillin, ciprofloxacin, tetracycline, streptomycin, and rifampin. Using Escherichia coli O18:K1:H7, we illustrate how precise estimates of the four parameters of the pharmacodynamic function can be obtained from in vitro time-kill data. We show that, in addition to their respective MICs, these antibiotics differ in the values of the other pharmacodynamic parameters. Using a computer simulation of antibiotic treatment in vivo, we demonstrate that, as a consequence of differences in pharmacodynamic parameters, such as the steepness of the Hill function and the minimum bacterial net growth rate attained at high antibiotic concen...Continue Reading

References

Mar 1, 1991·The Journal of Antimicrobial Chemotherapy·G CarretJ R Lobry
Aug 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·J G ZhiR Quintiliani
Sep 1, 1982·Antimicrobial Agents and Chemotherapy·I P ThonusM F Michel
Apr 1, 1982·The Journal of Infectious Diseases·A U GerberG Lebek
May 1, 1994·Antimicrobial Agents and Chemotherapy·M StanevaD Terziivanov
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·F GuerillotJ P Flandrois
Mar 1, 1993·Antimicrobial Agents and Chemotherapy·G L DrusanoH C Standiford
Feb 1, 1997·Antimicrobial Agents and Chemotherapy·M Lipsitch, B R Levin
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Jul 14, 1998·Antimicrobial Agents and Chemotherapy·S CorvaisierR W Jelliffe
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·F J BoswellA Dalhoff
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·A Dalhoff
Dec 20, 1999·The Journal of Antimicrobial Chemotherapy·K E BowkerA P MacGowan
Apr 19, 2000·Antimicrobial Agents and Chemotherapy·J C Fung-TomcD P Bonner
Aug 10, 2000·The Journal of Antimicrobial Chemotherapy·A MacGowanK Bowker
Nov 4, 2000·The Journal of Antimicrobial Chemotherapy·D H WrightJ C Rotschafer
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·I OdenholtO Cars
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·A LouieG L Drusano
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Apr 30, 2002·International Journal of Antimicrobial Agents·D Andes, W A Craig
Apr 30, 2002·International Journal of Antimicrobial Agents·Ping LiuHartmut Derendorf
Apr 30, 2002·International Journal of Antimicrobial Agents·Alexander A Vinks
Apr 30, 2002·International Journal of Antimicrobial Agents·Johan W MoutonGeorge L Drusano
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Myo-Kyoung KimDavid P Nicolau

❮ Previous
Next ❯

Citations

Feb 1, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E CaraherM Callaghan
Oct 2, 2007·Journal of Pharmacokinetics and Pharmacodynamics·David Czock, Frieder Keller
Jun 17, 2006·Nature Reviews. Microbiology·Bruce R Levin, Daniel E Rozen
Feb 17, 2009·The Journal of Antimicrobial Chemotherapy·Klas I UdekwuBruce R Levin
Oct 4, 2006·Proceedings. Biological Sciences·James J Bull, Roland R Regoes
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Philip ChungMartin E Evans
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·M AndraudM Laurentie
Jun 20, 2007·Antimicrobial Agents and Chemotherapy·Johan W MoutonAlexander A Vinks
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Sara K OlofssonOtto Cars
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·C WiuffB R Levin
May 21, 2011·BMC Evolutionary Biology·Fabian Svara, Daniel J Rankin
Jun 10, 2010·PLoS Computational Biology·Joseph Peter TorellaRoy Kishony
Feb 11, 2014·Mathematical Biosciences and Engineering : MBE·Mudassar Imran, Hal L Smith
Nov 5, 2014·Mathematical Biosciences and Engineering : MBE·Colette CalmeletPhilip Crooke
May 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Peter Ankomah, Bruce R Levin
May 7, 2009·Expert Opinion on Drug Metabolism & Toxicology·David CzockFrieder Keller
Aug 21, 2007·Journal of Pharmaceutical Sciences·Takayuki KatsubeYoshitaka Yano
Jul 16, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Olga A Vsevolozhskaya, James C Anthony
Dec 17, 2014·Journal of Theoretical Biology·Elsje PienaarJennifer J Linderman
Jun 9, 2009·Médecine et maladies infectieuses·F Van Bambeke, P M Tulkens
Dec 6, 2008·Journal of Theoretical Biology·Andreas HandelBruce R Levin
Jun 26, 2008·Journal of Theoretical Biology·James T MurphyMarc Devocelle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.